Cargando…
Progression of Prostate Cancer Despite an Extremely Low Serum Level of Prostate-Specific Antigen
A 61-year-old man who had been diagnosed with prostate cancer 9 years ago and had been treated with pelvic irradiation and intermittent androgen deprivation therapy visited the emergency room because of back pain and weakness in both legs. Spine magnetic resonance imaging showed a lumbar epidural ma...
Autores principales: | Lee, Dong Kil, Park, Jeong Hyun, Kim, Jae Han, Lee, Seung Joon, Jo, Moon Ki, Gil, Myung Cheol, Song, Kang Hyon, Park, Jong Wook |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Urological Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873892/ https://www.ncbi.nlm.nih.gov/pubmed/20495701 http://dx.doi.org/10.4111/kju.2010.51.5.358 |
Ejemplares similares
-
Prostate-Specific Antigen Mass and Free Prostate-Specific Antigen Mass for Predicting the Prostate Volume of Korean Men With Biopsy-Proven Benign Prostatic Hyperplasia
por: Park, Tae Yong, et al.
Publicado: (2013) -
Predictors of survival in prostate cancer patients with bone metastasis and extremely high prostate-specific antigen levels
por: Koo, Kyo Chul, et al.
Publicado: (2015) -
The Impact of the Percent of Residual Prostate-Specific Antigen on Metastasis-Free Survival in Patients with Persistent Prostate-Specific Antigen after Radical Prostatectomy
por: Lee, Dan Bee, et al.
Publicado: (2023) -
Early dutasteride monotherapy in men with detectable serum prostate-specific antigen levels following radical prostatectomy: A prospective trial
por: Shin, Yu Seob, et al.
Publicado: (2017) -
Association of serum prostate-specific antigen (PSA) level and circulating tumor cell-based PSA mRNA in prostate cancer
por: Cho, Hyungseok, et al.
Publicado: (2022)